Company / EPS (Diluted)
Apogee Therapeutics, Inc. EPS (Diluted) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$3.30
FY2024
5-year range
-$16.16 / -$3.30
FY2022-FY2024
Trend
+1.8%
vs FY2023
Sector context
#152 of 204
Health Care
What the data says
Apogee Therapeutics, Inc.'s eps (diluted) of $-3.30 is lower than 75% of companies in the Health Care sector (FY2024). Improved from $-16.16 to $-3.30 over the past 2 years.
Based on SEC 10-K filings.
-3.30 in FY2024.
Improved from $-16.16 to $-3.30 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 204This company -$3.30 Sector average -$0.89
▼
-272.4% below sector average
Key checks
Key Insights
- In FY2024, eps (diluted) increased 1.8% year-over-year.
- Ranks #152 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.30 | +1.8% |
| FY2023 | -$3.36 | +79.2% |
| FY2022 | -$16.16 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026